Free Newsletter
Scientists find potential Achilles heel in flu virus
Scientists at Rice University and the University of Texas in Austin say that they've found a weakness in the flu virus--both common flu viruses as well as bird flu--that could be a very effective target for new antiviral drugs. The target is the nucleoprotein, the flexible tail loop of the flu protein, often referred to as NP in shorthand. Any changes in the tail prevent the NPs from stacking together, a process that's necessary before cells begin to create the virus. A new antiviral that prevents the nucleoproteins from binding together could be a very effective method for preventing seasonal flu and ultimately guarding against a pandemic. Lead researcher Jane Tao says she is now studying thousands of compounds to see which is most likely to influence the NP.
- check out the press release on the finding
- here's the report on the research from The Houston Chronicle
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: